235 related articles for article (PubMed ID: 17212675)
1. Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
Ferrandina G; Carbone A; Zannoni GF; Martinelli E; Testa AC; Gallotta V; De Ninno M; Scambia G
J Obstet Gynaecol Res; 2007 Feb; 33(1):95-9. PubMed ID: 17212675
[TBL] [Abstract][Full Text] [Related]
2. Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma.
Shaco-Levy R; Piura B
J Obstet Gynaecol Res; 2008 Apr; 34(2):279-82. PubMed ID: 18412798
[TBL] [Abstract][Full Text] [Related]
3. Ovarian carcinosarcoma associated with bilateral tubal intraepithelial carcinoma: a case report.
Brustmann H
Int J Gynecol Pathol; 2013 Jul; 32(4):384-9. PubMed ID: 23722511
[TBL] [Abstract][Full Text] [Related]
4. Borderline serous cystadenocarcinoma with coexistent angiosarcoma: an unusual form of ovarian carcinosarcoma.
Pillay K; Essa AS; Chetty R
Int J Surg Pathol; 2001 Oct; 9(4):317-21. PubMed ID: 12574850
[TBL] [Abstract][Full Text] [Related]
5. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
[TBL] [Abstract][Full Text] [Related]
6. Colonic carcinoma metastasis to ovary having serous cystadenocarcinoma -- an unusual case of double ovarian malignancy.
Visweswara RN; Prabhu VM
Cent Afr J Med; 1995 Nov; 41(11):357-9. PubMed ID: 8932579
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma.
Krigman HR; Coogan AC; Marks JR
Arch Pathol Lab Med; 1995 Jan; 119(1):99-103. PubMed ID: 7802567
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
Seidman JD; Wang BG
Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
[TBL] [Abstract][Full Text] [Related]
9. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
10. Serous psammocarcinoma of the ovary: a case report and review of literature.
Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
[TBL] [Abstract][Full Text] [Related]
11. Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma.
Choi YD; Lee JS; Choi C; Park CS; Nam JH
Gynecol Oncol; 2007 Mar; 104(3):747-52. PubMed ID: 17229461
[TBL] [Abstract][Full Text] [Related]
12. Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
Ozbey C; Erdogan G; Pestereli HE; Simsek T; Karaveli S
APMIS; 2005 Oct; 113(10):713-5. PubMed ID: 16309432
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature.
Roma AA; Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Mar; 30(2):158-62. PubMed ID: 21293284
[TBL] [Abstract][Full Text] [Related]
14. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
15. Bilateral micropapillary serous carcinoma of the ovary: a case report.
Gupta R; Singh S; Nigam S
Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
Shvartsman HS; Sun CC; Bodurka DC; Mahajan V; Crispens M; Lu KH; Deavers MT; Malpica A; Silva EG; Gershenson DM
Gynecol Oncol; 2007 Jun; 105(3):625-9. PubMed ID: 17320156
[TBL] [Abstract][Full Text] [Related]
20. Minimal change disease in a patient with ovarian papillary serous carcinoma.
Ryu DR; Yoo TH; Kim YT; Jeong HJ; Cho NH; Kang SW
Gynecol Oncol; 2004 May; 93(2):554-6. PubMed ID: 15099980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]